Aseptic HLA B27-positive spondylodiscitis: decreased 18F-FDG uptake after etanercept treatment
AbstractWe observed a 69-year old man suffering from HLA B27 ankylosing spondylitis with persistent night back pain. 18F-FDG-PET/CT showed an increased metabolism at the level of the spinal space of L2-L3, L3-L4 with increased uptake compatible with spondylodiscitis. He started therapy with etanercept 50 mg/week. After six months of treatment repeated testing showed no uptake of the discs and vertebral bodies.
- Abstract views: 2593
- PDF: 516
Copyright (c) 2016 M. Benucci, A. Damiani, A. Arena, M. Infantino, M. Manfredi, F. Li Gobbi
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.